118 related articles for article (PubMed ID: 16167058)
1. Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.
Rund D; Krichevsky S; Bar-Cohen S; Goldschmidt N; Kedmi M; Malik E; Gural A; Shafran-Tikva S; Ben-Neriah S; Ben-Yehuda D
Leukemia; 2005 Nov; 19(11):1919-28. PubMed ID: 16167058
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype.
Ben-Yehuda D; Krichevsky S; Caspi O; Rund D; Polliack A; Abeliovich D; Zelig O; Yahalom V; Paltiel O; Or R; Peretz T; Ben-Neriah S; Yehuda O; Rachmilewitz EA
Blood; 1996 Dec; 88(11):4296-303. PubMed ID: 8943866
[TBL] [Abstract][Full Text] [Related]
3. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
4. Defective DNA-mismatch repair: a potential mediator of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia.
Olipitz W; Hopfinger G; Aguiar RC; Gunsilius E; Girschikofsky M; Bodner C; Hiden K; Linkesch W; Hoefler G; Sill H
Genes Chromosomes Cancer; 2002 Jun; 34(2):243-8. PubMed ID: 11979558
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability is not an uncommon finding in adult de novo acute myeloid leukemia.
Nomdedéu JF; Perea G; Estivill C; Lasa A; Carnicer MJ; Brunet S; Aventín A; Sierra J
Ann Hematol; 2005 Jun; 84(6):368-75. PubMed ID: 15789228
[TBL] [Abstract][Full Text] [Related]
6. Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis.
Christiansen DH; Andersen MK; Pedersen-Bjergaard J
J Clin Oncol; 2001 Mar; 19(5):1405-13. PubMed ID: 11230485
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
Larson RA; Wang Y; Banerjee M; Wiemels J; Hartford C; Le Beau MM; Smith MT
Blood; 1999 Jul; 94(2):803-7. PubMed ID: 10397748
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability.
Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L
Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112
[TBL] [Abstract][Full Text] [Related]
9. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia.
Naoe T; Takeyama K; Yokozawa T; Kiyoi H; Seto M; Uike N; Ino T; Utsunomiya A; Maruta A; Jin-nai I; Kamada N; Kubota Y; Nakamura H; Shimazaki C; Horiike S; Kodera Y; Saito H; Ueda R; Wiemels J; Ohno R
Clin Cancer Res; 2000 Oct; 6(10):4091-5. PubMed ID: 11051261
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association.
Chung TK; Cheung TH; Wang VW; Yu MY; Wong YF
Gynecol Obstet Invest; 2001; 52(2):98-103. PubMed ID: 11586036
[TBL] [Abstract][Full Text] [Related]
12. Two types of sporadic multiple colorectal cancers with and without HNPCC-like genetic instability.
Komura K; Masuda H; Esumi M
Hepatogastroenterology; 1999; 46(30):3115-20. PubMed ID: 10626171
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
Colović M; Suvajdžić N; Janković G; Tomin D; Colović N; Fekete MD; Palibrk V
Biomed Pharmacother; 2011 Aug; 65(5):319-21. PubMed ID: 21775097
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of microsatellite markers in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families.
Smolarz B; Romanowicz-Makowska H; Langner E; Kozlowska E; Kulig A; Dziki A
Exp Oncol; 2004 Sep; 26(3):205-9. PubMed ID: 15494688
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer?
Halvarsson B; Lindblom A; Rambech E; Lagerstedt K; Nilbert M
Virchows Arch; 2004 Feb; 444(2):135-41. PubMed ID: 14652751
[TBL] [Abstract][Full Text] [Related]
16. [Is immunohistochemistry for MLH1 and MSH2 proteins a useful method for detection of microsatellite instability in sporadic colorectal cancer?].
Do JH; Chang SK; Ahnn JY; Cha BK; Cheong SM; Kim DW; Cheong HR; Kim HJ; Kim JG; Lee TJ; Park ES; Park SM
Korean J Gastroenterol; 2003 Nov; 42(5):369-76. PubMed ID: 14646573
[TBL] [Abstract][Full Text] [Related]
17. Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer.
Dykes SL; Qui H; Rothenberger DA; García-Aguilar J
Cancer; 2003 Jul; 98(1):48-54. PubMed ID: 12833454
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
19. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
[TBL] [Abstract][Full Text] [Related]
20. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
